A researcher at the center of questions about a biotech’s controversial experimental treatment for Alzheimer’s disease has lost five papers in PLOS One. The journal says it is retracting the articles, by Hoau-Yan Wang and colleagues, over concerns about the integrity of the data and the images in the papers. Wang does not agree with … Continue reading Five studies linked to Cassava Sciences retracted
The chief scientific officer of a cannabis product company whose stock price has been hotter than a flaming joint (sorry) was known more than 18 months ago to have committed research misconduct while at the U.S. National Institutes of Health — casting a cloud of suspicion over the firm’s operations. Marketwatch reported yesterday that the … Continue reading Chief scientific officer of a high-flying cannabis product company faked data at the NIH
A former section chief at the National Institutes of Health who has had 19 papers retracted is no longer running a lab, Retraction Watch has learned. In the last three years, Stanley Rapoport, who is based at the U.S. National Institute on Aging (NIA), has lost 19 papers due to the misconduct of three different … Continue reading NIH section chief with 19 retractions is no longer running a lab
The string of apparent bad luck continues for Stanley Rapoport. Rapoport, a neuroscientist based at the U.S. National Institute on Aging, has lost three more papers in three journals due to the misconduct of his co-authors. By our count, these retractions bring his tally to 19 — and tie him for 21st place on our leaderboard. … Continue reading NIH neuroscientist up to 19 retractions
Neuroscientist Stanley Rapoport just can’t catch a break. Rapoport, who’s based at National Institute on Aging, is continuing to experience fallout from his research collaborations, after multiple co-authors have been found to have committed misconduct. Most recently, Rapoport has had four papers retracted in three journals, citing falsified data in a range of figures. Although the notices do not … Continue reading NIH neuroscientist up to 16 retractions
Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors. Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12. The latest batch of retractions … Continue reading Prominent NIH researcher up to a dozen retractions
Not again. That’s the sound of learning that a third scientist you worked with committed misconduct. In the last two years, we reported on two retractions for neuroscientist Stanley Rapoport, the result of misconduct by two different first authors. We’ve since discovered more retractions resulting from those cases — and a new retraction stemming from … Continue reading More co-author misconduct raises NIH neuroscientist’s retraction count to 8
Stanley Rapoport, a neuroscientist in the National Institute on Aging, isn’t having a lot of luck with his first authors. One committed misconduct and cost him a paper in the journal Age last year, and now he’s lost another paper with a different first author, but for the exact same reason. The latest paper, in … Continue reading NIH neuroscientist loses second paper, again the result of first author misconduct
Age has retracted a 2012 article by a group of scientists from the National Institutes of Health and Brigham and Women’s Hospital in Boston after an NIH inquiry turned up evidence of data manipulation in the work. The article, “Aging decreases rate of docosahexaenoic acid synthesis-secretion from circulating unesterified α-linolenic acid by rat liver,” came … Continue reading NIH/Harvard team loses aging study to manipulated data